Activity value 85germany Supplier,Last transaction date:
2025-05-09Address: alemania,hamburgo,esplanade 39 20354
Overview
Contact
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for naxon pharma trade gmbh from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 1 transactions, with a transaction quantity of 1268.84 and a transaction weight of 1268.84.
YearTransactionsQuantityWeight
20241631.15631.15
202511268.841268.84
Bill of lading data
<
1/15
>
Trade date
2025/05/09
B/L No.
92003003610980
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
bogota
Supply area
Germany
Purchas area
Colombia
Weight
1268.84kg
Amount
169204.23
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO BOG253246 PEDIDO PEDIDO 10001405 DECLARACION 1 DE 1;NOS ACOGEMOS AL ESTATUTO TRIBUTARIO, ARTICULO 477, MODIFICADO POR LA LEY 1819 DE 2016 BIENES QUE SE ENCUENTRAN EXENTOS DEL IMPUESTO DE IVA, NOS ACOGEMOS AL ACUERDO 124 CON LA UNION EUROPEA DECRETO 2247 DE 2014, CERTIFICADO DE ORIGEN EUR.1 N A 903139 FECHA: 07 05 2025 FACTURA:258100001, FECHA:07-05-2025, VISTO BUENO: VINVIMA-25-0025055 - FECHA: 21 02 2025 , PRODUCTO: HIDROXIUREA CAPSULAS 500 MG, NOMBRE COMERCIAL: HIDROXIUREA CAPSULAS 500 MG, PRINCIPIO ACTIVO: CADA CAPSULA DURA CONTIENE HIDROXIUREA HIDROXICARBAMIDA , CONCENTRACI N: 500 MG, INDICACIONES TERAP UTICAS: COADYUVANTE EN EL TRATAMIENTO DE LA LEUCEMIA MIELOCITICA CRONICA RESISTENTE, MELANOMA Y CARCINOMA DEL OVARIO RECURRENTE METASTASICO INOPERABLE. TERAPIA CONCOMITANTE A LA IRRADIACION EN EL CONTROL LOCAL DEL CARCINOMA PRIMARIO DE CELULAS ESCAMOSAS DE CABEZA Y CUELLO, EXCLUYENDO EL LABIO. TRATAMIENTO DE LA TROMBOCITEMIA ESENCIAL Y DE LA POLICITEMIA VERA, FORMA FARMAC UTICA: CAPSULA DURA, TIPO DE E
Expand
Trade date
2024/12/19
B/L No.
92003009499492
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
bogota
Supply area
Germany
Purchas area
Colombia
Weight
631.15kg
Amount
85623.7
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO BOG249784 PEDIDO PEDIDO 10001404 DECLARACION 1 DE 1;ESTATUTO TRIBUTARIO, ARTICULO 477, MODIFICADO POR LA LEY 1819 DE 2016 BIENES QUE SE ENCUENTRAN EXENTOS DEL IMPUESTO DE IVA // NOS ACOGEMOS AL ACUERDO 124 CON LA UNION EUROPEA DECRETO 2247 DE 2014, CERTIFICADO DE ORIGEN EUR.1 NO 903114 FECHA: 16/12/2024 //FACTURA:400183, FECHA:12-12-2024, VISTO BUENO: VINVIMA-24-0125455 FECHA: 01/10/2024 , PRODUCTO: MEDICAMENTO, NOMBRE COMERCIAL: HIDROXIUREA CAPSULAS 500 MG, PRINCIPIO ACTIVO: CADA CAPSULA DURA CONTIENEHIDROXIUREA (HIDROXICARBAMIDA), CONCENTRACION: 500 MG, INDICACIONES TERAPEUTICAS: COADYUVANTE EN EL TRATAMIENTO DE LA LEUCEMIA MIELOCITICA CRONICA RESISTENTE, MELANOMA Y CARCINOMADEL OVARIO RECURRENTE METASTASICO INOPERABLE. TERAPIA CONCOMITANTE A LA IRRADIACION EN EL CONTROL LOCAL DEL CARCINOMA PRIMARIO DE CELULAS ESCAMOSAS DE CABEZA Y CUELLO, EXCLUYENDO EL LABIO. TRATAMIENTO DE LA TROMBOCITEMIA ESENCIAL Y DE LA POLICITEMIA VERA, FORMA FARMACEUTICA: CAPSULA DURA, TIPO DE EMPAQUE: CAJA DE CARTON POR 10 BLIST
Expand
Trade date
2023/08/31
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Costa Rica
Purchas area
Colombia
Weight
1551.83kg
Amount
250035.32
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
OTHER MEDICINES FOR HUMAN USE
Expand
Trade date
2023/06/23
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Costa Rica
Purchas area
Colombia
Weight
120.55kg
Amount
542.25
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
OTHER MEDICINES FOR HUMAN USE
Expand
Trade date
2023/06/23
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Costa Rica
Purchas area
Colombia
Weight
1551.83kg
Amount
253633.12
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
OTHER MEDICINES FOR HUMAN USE
Expand
Trade date
2023/06/07
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Costa Rica
Purchas area
Colombia
Weight
70.8kg
Amount
22162.33
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
MEDICINES FOR ONCOLOGICAL OR HIV TREATMENT
Expand
Trade date
2023/01/12
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Costa Rica
Purchas area
Colombia
Weight
909.69
Amount
147442.76
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO BOG23035 PEDIDO PEDIDO 10001075 DECLARACION 1 DE 1NOS ACOGEMOS AL ACUERDO 124 CON LA UNION EUROPEA DECRETO 2247 DE 2
Expand
Trade date
2023/01/12
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Costa Rica
Purchas area
Colombia
Weight
909.69kg
Amount
147442.76
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
OTHER MEDICINES FOR HUMAN USE
Expand
Trade date
2022/08/17
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Germany
Purchas area
Colombia
Weight
909.67kg
Amount
142535.77
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
OTHER MEDICINES FOR HUMAN USE
Expand
Trade date
2022/08/17
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Germany
Purchas area
Colombia
Weight
909.67
Amount
142535.77
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO BOG226452 PEDIDO PEDIDO 10000982 DECLARACION 1 DE 1;NOS ACOGEMOS AL ESTATUTO TRIBUTARIO
Expand
Trade date
2022/05/12
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Germany
Purchas area
Colombia
Weight
133.2kg
Amount
268769.69
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
MEDICINES FOR ONCOLOGICAL OR HIV TREATMENT
Expand
Trade date
2022/05/12
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Germany
Purchas area
Colombia
Weight
133.2
Amount
268769.69
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO BOG223780 PEDIDO PEDIDO 10000942 DECLARACION 1 DE 1;NOS ACOGEMOS AL ESTATUTO TRIBUTARIO
Expand
Trade date
2022/04/25
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Germany
Purchas area
Colombia
Weight
967.05
Amount
149922.7
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
OTHER MEDICINES FOR HUMAN USE
Expand
Trade date
2022/04/25
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Germany
Purchas area
Colombia
Weight
967.05kg
Amount
149922.7
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
OTHER MEDICINES FOR HUMAN USE
Expand
Trade date
2022/03/16
B/L No.
——
Suppliers
naxon pharma trade gmbh
Buyers
al pharma s.a.
POLs
——
PODs
——
Supply area
Costa Rica
Purchas area
Colombia
Weight
38.1
Amount
141957.66
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO BOG221824 PEDIDO PEDIDO 10000941 DECLARACION 1 DE 1;ACOGEMOS AL ACUERDO COMERCIAL FIRMA
Expand
+View All
Partners
Total 7
RankCompanyTransactionsPerDetail
1al pharma s.a.
colombiabuyer,they trade on 2025-05-09
22195.26%
>
5fresenius kabi
argentinabuyer,they trade on 2015-05-22
20.86%
>
+View All
Products
Total 1
ProductsTransactionsPerDetail
equipped with fixed dose drug 7100%>
Hscode rank
Total 18
HSCode NameTransactionsPerDetail
HS 3004902900685.71%>
HS 3004902400114.29%>
Trading Area
Total 3
AreaTransactionsPerDetail
colombia22596.98%>
panama52.16%>
argentina20.86%>
naxon pharma trade gmbh is germany Supplier,
and primarily engages in the import and export business of products such as equipped with fixed dose drug.
According to the 52wmb.com global trade database, as of 2025-05-09, the company has completed 232 international trades,
with its main trading regions covering colombia,panama,argentina etc.
The core products include HS3004902900,HS3004902400 etc,
and its main trading partners are al pharma s.a.,b braun medical inc.,sun pharmaceutical services ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on naxon pharma trade gmbh is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.